UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000040254 |
|---|---|
| Receipt number | R000045749 |
| Scientific Title | Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature |
| Date of disclosure of the study information | 2020/05/01 |
| Last modified on | 2020/04/27 18:23:41 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A systematic review of return to community for long-term psychiatric inpatients
Acronym
A systematic review of return to community for long-term psychiatric inpatients
Scientific Title
Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature
Scientific Title:Acronym
Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature
Region
| Japan |
Condition
Condition
severe mental illness
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this systematic review is to examine readmission rates, readmission days, employment rates, and school enrollment rates after discharge focusing on psychiatric patients hospitalized for more than one year with a severe mental illness.
P:Adults with SMI
E:long-term (i.e. 1 year or longer) inpatient care in psychiatric hospitals or psychiatric wards in general hospitals
O:readmission, number of days in hospitals, number of days in community, and school/work engagement or other social participation after discharge
S:observational study, cohort study, and randomized controlled trial
Basic objectives2
Others
Basic objectives -Others
Same as above
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Readmission rate defined as the percentage of patients hospitalised during the first year after discharge and days of readmission defined as the number of days of hospitalization in the year after discharge
Key secondary outcomes
1)Readmission rates and readmission days within the follow-up period set by each study, other than those described in the previous section
2)Percentage of those discharged from hospitals who were employed enrolled in school or participated in social activities such as volunteering within the follow-up period set by each study
3)Level of severity in psychiatric symptoms measured by rating scales (e.g. PANSS, BPRS), level of social functioning measured by rating scales (e.g. GAF), quality of life, and well-being measured by self-report questionnaires (e.g.WHO-QOL26, SF36) at the end of the follow-up period set by each study
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
adults aged between 18 and 64 with diagnosis of severe mental illness who have been hospitalized 1 year or longer and were discharged from psychiatric inpatient care
Key exclusion criteria
Single diagnosis of mental disorders due to known physiological conditions (ICD-10 F0); psychoactive substance use (F1); anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders (F4); eating disorders (F50); adult personality and behavior (F6); intellectual disabilities (F7); or pervasive and specific developmental disorders (F8).
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Sayaka |
| Middle name | |
| Last name | Sato |
Organization
National Institute of Mental Health, NCNP
Division name
Department of Community Mental Health & Law
Zip code
1878553
Address
4-1-1 Ogawa-higashi Kodaira Tokyo Japan
TEL
0423462039
sayakas@ncnp.go.jp
Public contact
Name of contact person
| 1st name | Sayaka |
| Middle name | |
| Last name | Sato |
Organization
National Institute of Mental Health, NCNP
Division name
Department of Community Mental Health & Law
Zip code
187-8553
Address
4-1-1 Ogawa-higashi Kodaira Tokyo Japan
TEL
0423462039
Homepage URL
sayakas@ncnp.go.jp
Sponsor or person
Institute
National Institute of Mental Health, NCNP
Institute
Department
Personal name
Funding Source
Organization
National Institute of Mental Health, NCNP
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Institute of Mental Health, NCNP
Address
4-1-1 Ogawa-higashi Kodaira Tokyo Japan
Tel
0423462039
sayakas@ncnp.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2019 | Year | 10 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2019 | Year | 10 | Month | 31 | Day |
Last follow-up date
| 2020 | Year | 10 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We will report a narrative synthesis. Specifically, the country, year of publication, readmission rate, and the number of days of readmission for each article are summarized in a table. We will use meta-analytic techniques, if appropriate.
If there are ten or more studies in the systematic review, we will examine publication bias by visual inspection of funnel plots.
Management information
Registered date
| 2020 | Year | 04 | Month | 27 | Day |
Last modified on
| 2020 | Year | 04 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045749
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
